Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Perioperative subanesthetic esketamine for postoperative pain after gynecologic laparoscopic surgery
ChiCTR2200063985Phase 4Not yet recruiting
- Sponsor
- The First Affiliated Hospital of Zhengzhou University
- Start
- Oct 2021
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised trial of esketamine in acute postoperative pain (2 arms), sponsored by The First Affiliated Hospital of Zhengzhou University. Primary endpoint: Numerical rating scale score during movement at 24 hours after surgery. Planned start Oct 2021; status: not yet recruiting.
02
Drugs
esketamine
03
Conditions
acute postoperative pain
Beyond the preview
Go deeper on ChiCTR2200063985.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2200063985.